Reaction Details |
| Report a problem with these data |
Target | Bombesin receptor subtype-3 |
---|
Ligand | BDBM50381917 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_817747 (CHEMBL2027395) |
---|
IC50 | 0.5±n/a nM |
---|
Citation | Chobanian, HR; Guo, Y; Liu, P; Lanza, TJ; Chioda, M; Chang, L; Kelly, TM; Kan, Y; Palyha, O; Guan, XM; Marsh, DJ; Metzger, JM; Raustad, K; Wang, SP; Strack, AM; Gorski, JN; Miller, R; Pang, J; Lyons, K; Dragovic, J; Ning, JG; Schafer, WA; Welch, CJ; Gong, X; Gao, YD; Hornak, V; Reitman, ML; Nargund, RP; Lin, LS The design and synthesis of potent, selective benzodiazepine sulfonamide bombesin receptor subtype 3 (BRS-3) agonists with an increased barrier of atropisomerization. Bioorg Med Chem20:2845-9 (2012) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Bombesin receptor subtype-3 |
---|
Name: | Bombesin receptor subtype-3 |
Synonyms: | BRS-3 | BRS3 | BRS3_HUMAN | Bombesin 3 | Bombesin like receptor 3 |
Type: | Enzyme Catalytic Domain |
Mol. Mass.: | 44424.45 |
Organism: | Homo sapiens (Human) |
Description: | Bombesin 3 BRS3 HUMAN::P32247 |
Residue: | 399 |
Sequence: | MAQRQPHSPNQTLISITNDTESSSSVVSNDNTNKGWSGDNSPGIEALCAIYITYAVIISV
GILGNAILIKVFFKTKSMQTVPNIFITSLAFGDLLLLLTCVPVDATHYLAEGWLFGRIGC
KVLSFIRLTSVGVSVFTLTILSADRYKAVVKPLERQPSNAILKTCVKAGCVWIVSMIFAL
PEAIFSNVYTFRDPNKNMTFESCTSYPVSKKLLQEIHSLLCFLVFYIIPLSIISVYYSLI
ARTLYKSTLNIPTEEQSHARKQIESRKRIARTVLVLVALFALCWLPNHLLYLYHSFTSQT
YVDPSAMHFIFTIFSRVLAFSNSCVNPFALYWLSKSFQKHFKAQLFCCKAERPEPPVADT
SLTTLAVMGTVPGTGSIQMSEISVTSFTGCSVKQAEDRF
|
|
|
BDBM50381917 |
---|
n/a |
---|
Name | BDBM50381917 |
Synonyms: | CHEMBL2023112 |
Type | Small organic molecule |
Emp. Form. | C24H20F6N4O4S |
Mol. Mass. | 574.495 |
SMILES | CC(C)(C(N)=O)c1cccc2Nc3nc(ccc3CN(c12)S(=O)(=O)c1ccc(OC(F)(F)F)cc1)C(F)(F)F |
Structure |
|